World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
79
Citations
21767
World Ranking
1692
National Ranking
833

Medicine

D-Index
79
Citations
22537
World Ranking
17577
National Ranking
8788

Overview

Michael K. Racke is affiliated with Quest Diagnostics in the United States and has contributed extensively to the field of medicine, with a particular focus on neurology. Their scholarly work encompasses 66 publications primarily within medicine, covering multiple subfields including neurology, immunology, infectious diseases, pathology and forensic medicine, and physiology.

Their research topics span several areas, including:

  • Multiple Sclerosis Research Studies
  • Alzheimer's disease research and treatments
  • SARS-CoV-2 and COVID-19 Research
  • Peripheral Neuropathies and Disorders
  • Dementia and Cognitive Impairment Research
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers

Frequent publication venues for their work include:

  • Annals of Clinical and Translational Neurology
  • Journal of Neuroimmunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Neurology
  • Alzheimer s & Dementia

They have collaborated often with several co-authors, including:

  • Jennifer Graves
  • John A. Kessler
  • Leon G. Epstein
  • Ahmet Höke
  • Johns Hopkins

Among their recent published papers are:

  • "Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial" (2023) in The Lancet Neurology
  • "Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients" (2020) in Multiple Sclerosis Journal
  • "Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes" (2022) in Frontiers in Neurology
  • "A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg Balance" (2021) in JCI Insight
  • "Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer's disease assessment" (2024) in Frontiers in Neurology

Best Publications

  • Multiple Sclerosis — The Plaque and Its Pathogenesis

    Elliot M. Frohman;Michael K. Racke;Cedric S. Raine

  • Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

    M.K. Racke;A. Bonomo;D.E. Scott;B. Cannella

  • Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis: A Consensus Statement

    Mark S. Freedman;Edward J. Thompson;Florian Deisenhammer;Gavin Giovannoni

  • T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis

    Jeffrey M. Critchfield;Michael K. Racke;Juan Carlos Zúñiga-Pflücker;Barbara Cannella

  • Immune surveillance in multiple sclerosis patients treated with natalizumab

    Olaf Stüve;Olaf Stüve;Christina M Marra;Keith R Jerome;Keith R Jerome;Keith R Jerome;Linda Cook;Linda Cook;Linda Cook

  • Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.

    M K Racke;S Dhib-Jalbut;B Cannella;P S Albert

  • Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells

    Kamran Ghoreschi;Jürgen Brück;Christina Kellerer;Caishu Deng

  • Peroxisome Proliferator-Activated Receptor-γ Agonist 15-Deoxy-Δ12,1412,14-Prostaglandin J2 Ameliorates Experimental Autoimmune Encephalomyelitis

    Asim Diab;Caishu Deng;Jeff D. Smith;Rehana Z. Hussain

  • T-bet is essential for encephalitogenicity of both Th1 and Th17 cells.

    Yuhong Yang;Jeffrey Weiner;Yue Liu;Alan J. Smith

  • Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course.

    M. K. Racke;D. Burnett;Seong-Hee Pak;P. S. Albert

  • Factors that influence adherence with disease-modifying therapy in MS.

    Katherine Treadaway;Gary Cutter;Amber Salter;Sharon Lynch

  • High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay

    Michael P. Crawford;Shirley X. Yan;Sterling B. Ortega;Riyaz S. Mehta

  • Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.

    Amy E. Lovett-Racke;John L. Trotter;Joanne Lauber;Peter J. Perrin

  • T-bet Regulates the Fate of Th1 and Th17 Lymphocytes in Autoimmunity

    Anne R. Gocke;Petra D. Cravens;Li Hong Ben;Rehana Z. Hussain

  • Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.

    Olaf Stüve;Christina M. Marra;Amit Bar-Or;Masaaki Niino

  • IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease

    Martin Röcken;Michael Racke;Ethan M. Shevach

  • CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis.

    P J Perrin;J H Maldonado;T A Davis;C H June

  • Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

    R. Zivadinov;A. T. Reder;M. Filippi;A. Minagar

  • Effect of Rituximab on the Peripheral Blood and Cerebrospinal Fluid B Cells in Patients With Primary Progressive Multiple Sclerosis

    Nancy L. Monson;Petra D. Cravens;Elliot M. Frohman;Kathleen Hawker

  • The utility of MRI in suspected MS: report of the Therapeutics and technology assessment Subcommittee of the American Academy of Neurology

    EM Frohman;DS Goodin;PA Calabresi;JR Corboy

  • Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis

    Mark S. Freedman;Edward J. Thompson;Florian Deisenhammer;Gavin Giovannoni

Frequent Co-Authors

Amy E. Lovett-Racke
Amy E. Lovett-Racke The Ohio State University Wexner Medical Center
Elliot M. Frohman
Elliot M. Frohman The University of Texas at Austin
Olaf Stüve
Olaf Stüve The University of Texas Southwestern Medical Center
Anne H. Cross
Anne H. Cross Washington University in St. Louis
Bernhard Hemmer
Bernhard Hemmer Technical University of Munich
Dale E. McFarlin
Dale E. McFarlin National Institutes of Health
Carl H. June
Carl H. June University of Pennsylvania
Richard A. Nash
Richard A. Nash Fred Hutchinson Cancer Research Center
Henry F. McFarland
Henry F. McFarland National Institutes of Health
Douglas L. Arnold
Douglas L. Arnold Montreal Neurological Institute and Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can open diverse career options. Many students pursue advanced nursing programs, such as psychiatric nurse practitioner tracks. Finding the best pmhnp programs online ensures strong clinical placement opportunities, which are critical for gaining hands-on experience.

Cost is another important factor when selecting a program. The cheapest psychiatric nurse practitioner programs provide affordable pathways without compromising quality, making advanced education accessible to a wider range of students.

Career outlook is equally essential. Understanding how much do dnp nurses make can help guide financial and professional expectations. Salaries often vary by location, specialty, and certification, influencing long-term career decisions.

For those already in nursing, transitioning specializations is possible through certifications like acute care nurse practitioner certification. This step can broaden clinical skills and open doors to acute care settings, which may complement immunology-related roles.

Best Scientists Citing Michael K. Racke

Trending Scientists

Recently Published Articles